Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingcai Meng

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Cancer Cell International|April 8, 2021
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinomaRong Tang, Xiaomeng Liu, Wei Wang, et al.
Theranostics|January 18, 2021
Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatmentZeyin Rong, Jin Xu, Si Shi, et al.
Cancer Communications (London, England)|November 24, 2022
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectivesZengli Fang, Qingcai Meng, Jin Xu, et al.
Bioengineered|July 9, 2021
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment featuresYalan Lei, Rong Tang, Jin Xu, et al.
Molecular Cancer|March 4, 2020
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applicationsHeng Zhu, Miaoyan Wei, Jin Xu, et al.
Frontiers in Immunology|March 29, 2021
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal AdenocarcinomaRong Tang, Xiaomeng Liu, Chen Liang, et al.
Molecular Cell|September 27, 2016
TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune ResponsesMeixin Chen, Qingcai Meng, Yunfei Qin, et al.
Trials|August 17, 2023
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)Jialin Li, Si Shi, Jiang Liu, et al.
Frontiers in Plant Science|March 23, 2017
Dynamic Regulation of Auxin Response during Rice Development Revealed by Newly Established Hormone Biosensor MarkersJing Yang, Zheng Yuan, Qingcai Meng, et al.
Aging|November 23, 2020
The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionZhen Tan, Yubin Lei, Jin Xu, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Cancer Cell International|April 8, 2021
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinomaRong Tang, Xiaomeng Liu, Wei Wang, et al.
Theranostics|January 18, 2021
Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatmentZeyin Rong, Jin Xu, Si Shi, et al.
Cancer Communications (London, England)|November 24, 2022
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectivesZengli Fang, Qingcai Meng, Jin Xu, et al.
Bioengineered|July 9, 2021
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment featuresYalan Lei, Rong Tang, Jin Xu, et al.
Molecular Cancer|March 4, 2020
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applicationsHeng Zhu, Miaoyan Wei, Jin Xu, et al.
Frontiers in Immunology|March 29, 2021
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal AdenocarcinomaRong Tang, Xiaomeng Liu, Chen Liang, et al.
Molecular Cell|September 27, 2016
TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune ResponsesMeixin Chen, Qingcai Meng, Yunfei Qin, et al.
Trials|August 17, 2023
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)Jialin Li, Si Shi, Jiang Liu, et al.
Frontiers in Plant Science|March 23, 2017
Dynamic Regulation of Auxin Response during Rice Development Revealed by Newly Established Hormone Biosensor MarkersJing Yang, Zheng Yuan, Qingcai Meng, et al.
Aging|November 23, 2020
The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionZhen Tan, Yubin Lei, Jin Xu, et al.
Pageof 9